Goldman Sachs’s Biohaven BHVN Stock Holding History
Bought
Maintained
Sold
Other funds holding BHVN
SCM
JT
WP
IAM
Goldman Sachs's BHVN Position: Q2 2026 in Review
Goldman Sachs increased its Biohaven (BHVN) stake by 2.8% in Q2 2026, buying an estimated $752K and bringing the position to 2,583,046 shares worth $38.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.
Goldman Sachs first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $51.4M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.
- Goldman Sachs held 2,583,046 shares of Biohaven worth $38.4M as of Q2 2026.
- Goldman Sachs bought 69,865 Biohaven shares in Q2 2026, an estimated $752K.
- Biohaven made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2033 holding.
- Goldman Sachs first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
- Goldman Sachs's Biohaven position peaked at $51.4M in Q1 2024.
- 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.